Larvol Delta - ARTEMIDELung02-A-Global-Phase-III-Study-of-Rilvegostomig-or-Pembrolizumab-Plus-Chemotherapy-for-FirstLine-Treatment-of-Locally-Advanced-or-Metastatic-Squamous-Nonsmall-Cell-Lung-Cancer-NSCLC

albumin-bound paclitaxel - Generic mfg.

carboplatin - Generic mfg.

rilvegostomig (AZD2936) - AstraZeneca

Keytruda (pembrolizumab) - Merck (MSD)

http://clinicaltrials.gov/ct2/show/NCT06692738

Jul 15, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next